Published in Am J Med Genet on December 15, 1999
Influence of pH on the human prion protein: insights into the early steps of misfolding. Biophys J (2010) 0.93
Copper binding extrinsic to the octarepeat region in the prion protein. Curr Protein Pept Sci (2009) 0.91
Checking the pH-induced conformational transition of prion protein by molecular dynamics simulations: effect of protonation of histidine residues. Biophys J (2004) 0.90
Stability and Cu(II) binding of prion protein variants related to inherited human prion diseases. Biophys J (2003) 0.88
Structural and dynamic properties of the human prion protein. Biophys J (2014) 0.82
Decrypting Prion Protein Conversion into a β-Rich Conformer by Molecular Dynamics. J Chem Theory Comput (2013) 0.78
Searching for factors that distinguish disease-prone and disease-resistant prions via sequence analysis. Bioinform Biol Insights (2008) 0.75
Systematic investigation of predicted effect of nonsynonymous SNPs in human prion protein gene: a molecular modeling and molecular dynamics study. J Biomol Struct Dyn (2013) 0.75
Missing value estimation methods for DNA microarrays. Bioinformatics (2001) 20.84
Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol (1994) 9.41
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology (1996) 8.82
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc Natl Acad Sci U S A (1988) 6.74
La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J Virol (1993) 5.89
Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science (1968) 5.76
Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol (1979) 5.53
Spatial patterns in the distribution of tropical tree species. Science (2000) 5.46
'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol (2000) 5.29
Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol (1994) 5.20
The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med (1996) 5.06
Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet (1974) 4.95
Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology (1997) 4.93
International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci (1997) 4.50
Human immunodeficiency virus integration in a cell-free system. J Virol (1990) 4.48
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (1997) 4.43
Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature (1966) 4.29
Genetic control of natural variation in Arabidopsis glucosinolate accumulation. Plant Physiol (2001) 4.07
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science (1992) 3.93
Activation of the primary visual cortex by Braille reading in blind subjects. Nature (1996) 3.91
TIF4631 and TIF4632: two yeast genes encoding the high-molecular-weight subunits of the cap-binding protein complex (eukaryotic initiation factor 4F) contain an RNA recognition motif-like sequence and carry out an essential function. Mol Cell Biol (1993) 3.85
Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med (1998) 3.62
Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet (1977) 3.58
Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain (1994) 3.57
Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology (1996) 3.57
Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med (1997) 3.35
Community clinics for leg ulcers and impact on healing. BMJ (1992) 3.28
Modulation of muscle responses evoked by transcranial magnetic stimulation during the acquisition of new fine motor skills. J Neurophysiol (1995) 3.27
Rapid plasticity of human cortical movement representation induced by practice. J Neurophysiol (1998) 3.26
A physiological mechanism of bradykinesia. Brain (1980) 3.15
Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry (1997) 3.02
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
Real and imagined clinicopathological limits of "prion dementia". Lancet (1993) 2.96
Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev (1999) 2.96
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
Dose standardisation of botulinum toxin. Lancet (1989) 2.83
Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci U S A (1999) 2.76
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Bias inherent in retrospective waiting-time studies: experience from a vascular surgery waiting list. CMAJ (2000) 2.74
EMG analysis of stereotyped voluntary movements in man. J Neurol Neurosurg Psychiatry (1975) 2.71
Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology (2004) 2.70
Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol (1991) 2.68
Transmission and passage of experimenal "kuru" to chimpanzees. Science (1967) 2.64
Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem (1993) 2.59
Detection of flaviviruses by reverse-transcriptase polymerase chain reaction. J Med Virol (1991) 2.59
Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci U S A (1991) 2.55
The foamy viruses. Bacteriol Rev (1975) 2.53
The pathophysiology of primary dystonia. Brain (1998) 2.51
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Further evidence for small-bodied hominins from the Late Pleistocene of Flores, Indonesia. Nature (2005) 2.47
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology (1987) 2.46
Ribonuclease activity of Petunia inflata S proteins is essential for rejection of self-pollen. Plant Cell (1994) 2.45
An extremely luminous X-ray outburst at the birth of a supernova. Nature (2008) 2.41
Modulation of cortical motor output maps during development of implicit and explicit knowledge. Science (1994) 2.41
Optimal focal transcranial magnetic activation of the human motor cortex: effects of coil orientation, shape of the induced current pulse, and stimulus intensity. J Clin Neurophysiol (1992) 2.38
Functional relevance of cross-modal plasticity in blind humans. Nature (1997) 2.36
Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patients. Lancet (1985) 2.35
Infection-specific particle from the unconventional slow virus diseases. Science (1984) 2.34
Postural electromyographic responses in the arm and leg following galvanic vestibular stimulation in man. Exp Brain Res (1993) 2.30
Internal translation initiation on poliovirus RNA: further characterization of La function in poliovirus translation in vitro. J Virol (1994) 2.30
Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses. J Virol (1987) 2.28
Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr Clin Neurophysiol (1992) 2.27
Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients. Aliment Pharmacol Ther (2014) 2.27
New clinical sign for orthostatic tremor. Lancet (1995) 2.25
Pathophysiology of bradykinesia in Parkinson's disease. Brain (2001) 2.24
Feedforward ankle strategy of balance during quiet stance in adults. J Physiol (1999) 2.24
Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants. FEBS Lett (2000) 2.22
Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry (1998) 2.22
Gastric cancer detection in gastric ulcer disease. Gut (1980) 2.20
Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet (1998) 2.17
The new biology of spongiform encephalopathy: infectious amyloidoses with a genetic twist. Lancet (1991) 2.16
Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man. J Pharmacol Exp Ther (1965) 2.16
Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma--a study based on 420 patients. J Hepatol (1996) 2.15
Bovine spongiform encephalopathy [corrected] Creutzfeldt-Jakob disease. BMJ (1996) 2.15
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis (1975) 2.14
Non-haemolytic beta-amino-acid oligomers. Nature (2000) 2.11
Endoscopic resection of submucosal tumor of the esophagus: results in 62 patients. Endoscopy (1997) 2.11
Nervous system reorganization following injury. Neuroscience (2002) 2.11
Magnetic stimulation: motor evoked potentials. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl (1999) 2.10
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease). N Engl J Med (1977) 2.10
Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med (1985) 2.09
Evidence for widespread infection of wild rats with hepatitis E virus in the United States. Am J Trop Med Hyg (1999) 2.08
Ballistic flexion movements of the human thumb. J Physiol (1979) 2.06
Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol (1986) 2.06
Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med (1986) 2.06
Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport (1995) 2.06